Therapeutic Asset Ratings
25,363 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
LENVATINIB
Stage IIB Breast Cancer
University Medical Center Groningen
P4
BBB
(73)
Letrozole
Breast Carcinoma
OHSU Knight Cancer Institute
P4
BBB
(73)
Letrozole
Polycystic Ovary Syndrome
Fatima Tariq
P4
BBB
(73)
Letrozole
Breast Carcinoma
OHSU Knight Cancer Institute
P4
BBB
(73)
LIDOCAINE
Back Pain
Medical University of Lublin
P4
BBB
(73)
LIDOCAINE
Carpal Tunnel Syndrome
Haydarpasa Numune Training and Research Hospital
P4
BBB
(73)
LIDOCAINE
Opioid Use Disorder
Jacques E. Chelly
P4
BBB
(73)
LIDOCAINE
Pain, Postoperative
Ataturk University
P4
BBB
(73)
LIDOCAINE
Pudendal Neuralgia
Groupe Hospitalier Diaconesses Croix Saint-Simon
P4
BBB
(73)
LIDOCAINE
Sciatica
C.L.A.Vleggeert-Lankamp
P4
BBB
(73)
Lorazepam
Schizoaffective Disorder
Temple University
P4
BBB
(73)
Metformin
Nonalcoholic Steatohepatitis
Altimmune, Inc.
P4
BBB
(73)
METHADONE
Opiate Addiction
University of Maryland, Baltimore
P4
BBB
(73)
METHOTREXATE
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P4
BBB
(73)
MIDAZOLAM
Choledocholithiasis
National University of Malaysia
P4
BBB
(73)
MIDAZOLAM
Type 2 Diabetes Mellitus
Pfizer
P4
BBB
(73)
Misoprostol
Obstetric Disorder
University of Texas at Austin
P4
BBB
(73)
MIVACURIUM ION
Anesthesia, Intravenous
Helse Fonna
P4
BBB
(73)
Montelukast
Asthma
Kafrelsheikh University
P4
BBB
(73)
NEPENTHE
Acute Pain
Ondokuz Mayıs University
P4
BBB
(73)
NEPENTHE
Analgesia
Meri Mirceta
P4
BBB
(73)
NEPENTHE
Post-Operative Pain, Non-Human Animal
IVO JURISIC
P4
BBB
(73)
Nintedanib
Idiopathic Pulmonary Fibrosis
Mannkind Corporation
P4
BBB
(73)
Olaparib
Breast Carcinoma
The Netherlands Cancer Institute
P4
BBB
(73)
Orelabrutinib
Marginal Zone Lymphoma
Henan Cancer Hospital
P4
BBB
(73)
Showing 451 to 475 of 25,363 assets
Previous
Page 19 of 1015
Next